A SENSITIVE, ECONOMICAL BIOANALYTICAL LC-MS/MS METHOD FOR SIMULTANEOUS ANALYSIS OF IRBESARTAN AND HYDROCHLOROTHIAZIDE

Q4 Pharmacology, Toxicology and Pharmaceutics INDIAN DRUGS Pub Date : 2023-07-03 DOI:10.53879/id.60.06.13200
Celina Nazareth, S. Pereira, R. Batheja
{"title":"A SENSITIVE, ECONOMICAL BIOANALYTICAL LC-MS/MS METHOD FOR SIMULTANEOUS ANALYSIS OF IRBESARTAN AND HYDROCHLOROTHIAZIDE","authors":"Celina Nazareth, S. Pereira, R. Batheja","doi":"10.53879/id.60.06.13200","DOIUrl":null,"url":null,"abstract":"A novel bioanalytical LC-MS/MS method for irbesartan and hydrochlorothiazide has been developed using deuterated internal standards. Sample pretreatment was carried out using Strata-X Cartridge 33µm. Chromatographic separation was achieved on Chromolith® High Resolution Column, 100X4.6mm, 5µ using a mobile phase of acetonitrile (80 %) and 2mM ammonium acetate (20 %) basified with ammonia solution. A flow rate of 1 mL min-1 was employed with split ratio of approximately 50% outside, with column temperature being 40˚C ±2˚C. The retention time for irbesartan and irbesartanD4 deuterated internal standard was 1.52 min (±0.50min) and for hydrochlorothiazide and hydrochlorothiazide15N213CD2 deuterated internal standard it was 1.43 min (±0.50 min). The developed LC/MS-MS method was validated as per EMA guidelines. The linearity range established for the drugs in human plasma was 50.197 ng mL-1 to 6038.206 ng mL-1 for irbesartan and 1.021 ng mL-1 to 408.480 ng mL-1 for hydrochlorothiazide. The short run time ensured use of less mobile phase and increased sample throughput, making analysis rapid and economical.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INDIAN DRUGS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53879/id.60.06.13200","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

A novel bioanalytical LC-MS/MS method for irbesartan and hydrochlorothiazide has been developed using deuterated internal standards. Sample pretreatment was carried out using Strata-X Cartridge 33µm. Chromatographic separation was achieved on Chromolith® High Resolution Column, 100X4.6mm, 5µ using a mobile phase of acetonitrile (80 %) and 2mM ammonium acetate (20 %) basified with ammonia solution. A flow rate of 1 mL min-1 was employed with split ratio of approximately 50% outside, with column temperature being 40˚C ±2˚C. The retention time for irbesartan and irbesartanD4 deuterated internal standard was 1.52 min (±0.50min) and for hydrochlorothiazide and hydrochlorothiazide15N213CD2 deuterated internal standard it was 1.43 min (±0.50 min). The developed LC/MS-MS method was validated as per EMA guidelines. The linearity range established for the drugs in human plasma was 50.197 ng mL-1 to 6038.206 ng mL-1 for irbesartan and 1.021 ng mL-1 to 408.480 ng mL-1 for hydrochlorothiazide. The short run time ensured use of less mobile phase and increased sample throughput, making analysis rapid and economical.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种灵敏、经济的同时分析厄贝沙坦和氢氯噻嗪的lc-ms / ms方法
采用氘化内标建立了一种新的生物分析LC-MS/MS法测定厄贝沙坦和氢氯噻嗪。使用33µm Strata-X滤筒进行样品预处理。色谱分离在Chromolith®高分辨率柱(100X4.6mm,5µ)上实现,使用乙腈(80%)和用氨溶液碱化的2mM乙酸铵(20%)的流动相。采用1 mL min-1的流速,外部分流率约为50%,柱温为40˚C±2˚C。厄贝沙坦和厄贝沙坦D4氘化内标的保留时间为1.52分钟(±0.50分钟),氢氯噻嗪和氢氯噻肼15N213CD2氘化内标准的保留时间是1.43分钟(±0.5分钟)。所开发的LC/MS-MS方法按照EMA指南进行了验证。药物在人血浆中的线性范围为:厄贝沙坦为50.197 ng/mL-1至6038.206 ng/mL-1,氢氯噻嗪为1.021 ng/mL-1到408.480 ng/mL-1。运行时间短,确保了使用更少的流动相,提高了样品吞吐量,使分析快速而经济。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
INDIAN DRUGS
INDIAN DRUGS Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
0.30
自引率
0.00%
发文量
98
期刊最新文献
COMPUTATIONAL IDENTIFICATION OF SELECTED BIOACTIVE COMPOUNDS FROM CEDRUS DEODARA AS INHIBITORS AGAINST SARS-COV-2 MAIN PROTEASE: A PHARMACOINFORMATICS STUDY PREPARATION AND CHARACTERIZATION OF MICROSPHERES UTILIZING RATE-CONTROLLING MEMBRANES FOR THE MANAGEMENT OF DIABETES MELLITUS PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY NEED/ROLE OF GENERATIVE AI IN PHARMACEUTICAL RESEARCH THE GENUS LITSEA: A REVIEW OF ITS CYTOTOXIC POTENTIAL AND PHYTOCHEMISTRY
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1